SHANGHAI, July 1, 2025 /PRNewswire/ -- As Boqii Holding Limited ("Boqii" or the "Company") (NYSE American: BQ) previously announced, the Company plans to cease the listing...
2026 Kia Sportage PHEV pricing starts at $40,4901 Refreshed X-Line and X-Line Prestige models blend comfort and power "Opposites United" design philosophy takes on a more confident...
CHANGZHOU, China, July 1, 2025 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or "we", "our", or the "Company"), a leading short-distance transportation solutions...
Vastned NV has received on 30 June 2025 a transparency notification dated 30 June 2025, which indicates that Wassenaar OG B.V., as a result of the acquisition of shares on 30 June 2025, now holds more than 10% of the voting rights of Vastned NV. Wassenaar OG B.V. has thus crossed the 10% threshold (upward).
OSLO, Norway, July 1, 2025 /PRNewswire/ -- Opera Limited (NASDAQ: OPRA), one of the world's major browser developers and a leading internet consumer brand, is...
OSLO, Norway, June 30, 2025 /PRNewswire/ -- BerGenBio ASA the ("Company") hereby announces a fully underwritten rights issue with preferential subscription rights (the "Subscription...
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU AND UK MARKET ABUSE REGIMES June...
Low Credit Finance outlines expanded platform features to help connect borrowers with payday loan options that minimize traditional credit checks, offering streamlined applications and flexible repayment pathways.
Low Credit Finance outlines expanded platform features to help connect borrowers with payday loan options that minimize traditional credit checks, offering streamlined applications and flexible repayment pathways.
ATLANTA, June 27, 2025 /PRNewswire/ -- Norfolk Southern Corporation (NYSE: NSC) will announce its second quarter 2025 financial results during a live conference call...
SAN FRANCISCO, June 25, 2025 (GLOBE NEWSWIRE) -- Biotechnology firm Iovance Biotherapeutics Inc. (NASDAQ: IOVA) announced a significant leadership transition, confirming the resignation of Chief Financial Officer Jean-Marc Bellemin, effective July 10, 2025. Mr. Bellemin, who assumed the CFO role in November 2020, is reportedly departing to pursue other endeavors, according to a regulatory filing. Bellemin’s exit comes at a tumultuous time, as the company is grappling with a recent commercial setback for its flagship drug, Amtagvi, and the specter of a class-action securities lawsuit.
Customers report losses of over $190,000 during 2025
OAKLAND, Calif., June 25, 2025 /PRNewswire/ -- Utility scams have continued at an alarming rate during 2025,...
Enhancements enable users to easily use AI-generated insights and recommendations to effectively manage equipment operations and maintenance
KENNESAW, Ga., June 25, 2025 /PRNewswire/ -- Carrier's...